688136 科兴制药
已收盘 11-06 15:00:00
资讯
新帖
简况
科兴制药（688136）10月30日主力资金净卖出60.72万元
证券之星 · 10-31
科兴制药（688136）10月30日主力资金净卖出60.72万元
10月30日科兴制药（688136）龙虎榜数据：机构净买入974.5万元，北向资金净买入343.8万元
证券之星 · 10-30
10月30日科兴制药（688136）龙虎榜数据：机构净买入974.5万元，北向资金净买入343.8万元
科兴制药前三季扣非亏损 2020上市募11亿中信建投保荐
中金财经 · 10-30
科兴制药前三季扣非亏损 2020上市募11亿中信建投保荐
科兴制药2026年前三季度实现营收9.14亿元
同花顺 · 10-30
科兴制药2026年前三季度实现营收9.14亿元
图解科兴制药三季报：第三季度单季净利润同比下降448.93%
证券之星 · 10-30
图解科兴制药三季报：第三季度单季净利润同比下降448.93%
科兴制药(688136)9月30日股东户数1.66万户，较上期增加25.95%
证券之星 · 10-29
科兴制药(688136)9月30日股东户数1.66万户，较上期增加25.95%
科兴制药（688136）10月27日主力资金净卖出960.03万元
证券之星 · 10-28
科兴制药（688136）10月27日主力资金净卖出960.03万元
科兴制药（688136）10月13日主力资金净卖出1290.45万元
证券之星 · 10-14
科兴制药（688136）10月13日主力资金净卖出1290.45万元
股市必读：科兴制药新发布《自愿披露关于聚乙二醇化人粒细胞刺激因子注射液上市许可申请获得受理的公告》
证券之星 · 10-12
股市必读：科兴制药新发布《自愿披露关于聚乙二醇化人粒细胞刺激因子注射液上市许可申请获得受理的公告》
科兴制药(688136.SH)：聚乙二醇化人粒细胞刺激因子注射液上市许可申请获受理
智通财经 · 10-09
科兴制药(688136.SH)：聚乙二醇化人粒细胞刺激因子注射液上市许可申请获受理
科兴制药：GB-K02申请获受理，规格6mg/0.6ml/支
格隆汇 · 10-09
科兴制药：GB-K02申请获受理，规格6mg/0.6ml/支
科兴制药（688136）9月29日主力资金净买入4084.72万元
证券之星 · 09-30
科兴制药（688136）9月29日主力资金净买入4084.72万元
科兴生物制药（688136）9月23日主力资金净卖出1658.90万元
证券之星 · 09-24
科兴生物制药（688136）9月23日主力资金净卖出1658.90万元
科兴制药(688136.SH)：GB20注射液获得药物临床试验批准通知书
智通财经 · 09-21
科兴制药(688136.SH)：GB20注射液获得药物临床试验批准通知书
每周股票复盘：科兴制药（688136）将参加科创板创新药业绩说明会
证券之星 · 09-13
每周股票复盘：科兴制药（688136）将参加科创板创新药业绩说明会
科兴制药新提交“-”商标注册申请
证券之星 · 09-11
科兴制药新提交“-”商标注册申请
科兴制药（688136）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价上涨2.42%
证券之星 · 09-08
科兴制药（688136）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价上涨2.42%
每周股票复盘：机构净卖出科兴制药（688136）519.2万元
证券之星 · 08-30
每周股票复盘：机构净卖出科兴制药（688136）519.2万元
科兴制药半年报净利大增66%，扣非却亏7836万：主业低迷依赖私募基金价值变动，大股东连续套现
蓝鲸财经 · 08-25
科兴制药半年报净利大增66%，扣非却亏7836万：主业低迷依赖私募基金价值变动，大股东连续套现
8月24日科兴制药涨14.84%，国联医疗健康混合A基金重仓该股
证券之星 · 08-24
8月24日科兴制药涨14.84%，国联医疗健康混合A基金重仓该股
加载更多
公司概况
公司名称：
科兴生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2020-12-14
主营业务：
科兴生物制药股份有限公司的主营业务是重组蛋白、抗体及靶向递送疗法的研发、生产与商业化。公司的主要产品是赛若金、依普定、白特喜、常乐康、引进产品。
发行价格：
22.33
{"stockData":{"symbol":"688136","market":"SH","secType":"STK","nameCN":"科兴制药","latestPrice":15.53,"timestamp":1793948400000,"preClose":16,"halted":0,"volume":5155837,"delay":0,"changeRate":-0.0294,"floatShares":202000000,"shares":202000000,"eps":0.3484,"marketStatus":"已收盘","change":-0.47,"latestTime":"11-06 15:00:00","open":15.6,"high":15.9,"low":15.32,"amount":80464200,"amplitude":0.0363,"askPrice":15.54,"askSize":89,"bidPrice":15.53,"bidSize":67,"shortable":0,"etf":0,"ttmEps":0.3484,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":16,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":17.6,"lowLimit":14.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201985000,"isCdr":false,"pbRate":1.8,"roa":"--","peRate":44.575201,"roe":"1.49%","epsLYR":0.79,"committee":0.370286,"marketValue":3137000000,"turnoverRate":0.0255,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-09。","afterMarket":{"amount":72804.64,"volume":4688,"close":15.53,"buyVolume":0,"sellVolume":15159,"time":1793950437746,"indexStatus":"已收盘 11-06 15:30:00","preClose":16},"floatMarketCap":3137000000},"requestUrl":"/m/hq/s/688136","defaultTab":"news","newsList":[{"id":"2679229853","title":"科兴制药（688136）10月30日主力资金净卖出60.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679229853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679229853?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:24","pubTimestamp":1793406245,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，科兴制药报收于15.84元，下跌16.72%，换手率6.27%，成交量12.66万手，成交额2.04亿元。近5日资金流向一览见下表：科兴制药融资融券信息显示，融资方面，当日融资买入1869.89万元，融资偿还2634.25万元，融资净偿还764.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679263215","title":"10月30日科兴制药（688136）龙虎榜数据：机构净买入974.5万元，北向资金净买入343.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679263215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679263215?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:37","pubTimestamp":1793360247,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年10月30日公布的交易公开信息显示，科兴制药因有价格涨跌幅限制的日收盘价格跌幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年10月30日收盘，科兴制药报收于15.84元，下跌16.72%，换手率6.27%，成交量12.66万手，成交额2.04亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入974.5万元，北向资金合计净买入343.8万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679269266","title":"科兴制药前三季扣非亏损 2020上市募11亿中信建投保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2679269266","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679269266?lang=zh_cn&edition=full","pubTime":"2026-10-30 14:34","pubTimestamp":1793342052,"startTime":"0","endTime":"0","summary":"中国经济网北京10月30日讯 科兴制药 昨晚发布2026年第三季度报告显示，前三季度公司实现营业收入9.14亿元，同比下降20.38%；归属于上市公司股东的净利润2605.8万元，同比下降76.58%；归属于上市公司股东的扣除非经常性损益的净利润-1.66亿元，同比下降335.75%；经营活动产生的现金流量净额为644.92万元。 科兴制药首次公开发行股票的发行费用(含税)总额为1.15亿元，其中，保荐及承销费用9385.58万元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/30/20261030665941.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/30/20261030665941.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261030/32411893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688136","BK0239","IPOS","601066","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679256723","title":"科兴制药2026年前三季度实现营收9.14亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679256723","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679256723?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:45","pubTimestamp":1793321100,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯(记者赵彬彬)10月29日晚间，科兴制药公告称，2026年前三季度，公司实现营业收入9.14亿元，实现归母净利润2605.80万元。公司表示，营收、利润下降主要系受集采扩面、公司 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261030/c681269788.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261030/c681269788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679287130","title":"图解科兴制药三季报：第三季度单季净利润同比下降448.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679287130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679287130?lang=zh_cn&edition=full","pubTime":"2026-10-30 01:12","pubTimestamp":1793293948,"startTime":"0","endTime":"0","summary":"证券之星消息，科兴制药2026年三季报显示，前三季度公司主营收入9.14亿元，同比下降20.38%；归母净利润2605.8万元，同比下降76.58%；扣非净利润-1.66亿元，同比下降335.75%；其中2026年第三季度，公司单季度主营收入3.07亿元，同比下降31.43%；单季度归母净利润-1.08亿元，同比下降448.93%；单季度扣非净利润-8772.19万元，同比下降448.55%；负债率52.94%，投资收益393.24万元，财务费用4653.2万元，毛利率52.2%。财报数据概要请见下图:本文数据来源于科兴制药2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000003245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679408287","title":"科兴制药(688136)9月30日股东户数1.66万户，较上期增加25.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679408287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679408287?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:56","pubTimestamp":1793271385,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科兴制药披露，截至2026年9月30日公司股东户数为1.66万户，较6月30日增加3422.0户，增幅为25.95%。在生物制品行业个股中，科兴制药股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.6万户。从股价来看，2026年6月30日至2026年9月30日，科兴制药区间涨幅为17.19%，在此期间股东户数增加3422.0户，增幅为25.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900044976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678802174","title":"科兴制药（688136）10月27日主力资金净卖出960.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678802174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678802174?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:46","pubTimestamp":1793148381,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，科兴制药报收于18.95元，下跌6.0%，换手率2.97%，成交量6.01万手，成交额1.17亿元。近5日资金流向一览见下表：科兴制药融资融券信息显示，融资方面，当日融资买入1355.11万元，融资偿还1708.33万元，融资净偿还353.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675395772","title":"科兴制药（688136）10月13日主力资金净卖出1290.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675395772","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675395772?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:28","pubTimestamp":1791937733,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，科兴制药报收于21.94元，下跌2.53%，换手率3.26%，成交量6.59万手，成交额1.45亿元。近5日资金流向一览见下表：科兴制药融资融券信息显示，融资方面，当日融资买入1005.98万元，融资偿还1410.46万元，融资净偿还404.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674450318","title":"股市必读：科兴制药新发布《自愿披露关于聚乙二醇化人粒细胞刺激因子注射液上市许可申请获得受理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674450318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674450318?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:55","pubTimestamp":1791744912,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，科兴制药报收于23.24元，下跌0.51%，换手率3.7%，成交量7.46万手，成交额1.7亿元。公司公告汇总：科兴制药收到国家药监局关于聚乙二醇化人粒细胞刺激因子注射液上市许可申请的《受理通知书》，受理号CXSS2600161。该产品适用于非髓性恶性肿瘤患者在接受化疗时降低发热性中性粒细胞减少症的感染发生率，为原研Neulasta的生物类似药。目前该药品上市申请尚需国家药监局进一步审评审批，存在不确定性，对公司近期业绩无影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785403","title":"科兴制药(688136.SH)：聚乙二醇化人粒细胞刺激因子注射液上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785403","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674785403?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:58","pubTimestamp":1791550688,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的关于公司在研药品聚乙二醇化人粒细胞刺激因子注射液(简称“GB-K02”)药品上市许可申请的《受理通知书》。公司GB-K02适用于非髓性恶性肿瘤患者在接受易引起临床上显著的发热性中性粒细胞减少的骨髓抑制性抗癌药物治疗时，降低以发热性中性粒细胞减少症为表现的感染发生率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674309856","title":"科兴制药：GB-K02申请获受理，规格6mg/0.6ml/支","url":"https://stock-news.laohu8.com/highlight/detail?id=2674309856","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674309856?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:02","pubTimestamp":1791543761,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671929225","title":"科兴制药（688136）9月29日主力资金净买入4084.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671929225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671929225?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:23","pubTimestamp":1790727789,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，科兴制药报收于23.57元，上涨2.79%，换手率5.06%，成交量10.21万手，成交额2.43亿元。近5日资金流向一览见下表：科兴制药融资融券信息显示，融资方面，当日融资买入2391.67万元，融资偿还1881.44万元，融资净买入510.23万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437908","title":"科兴生物制药（688136）9月23日主力资金净卖出1658.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437908","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669437908?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:34","pubTimestamp":1790210046,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，科兴生物制药报收于24.59元，下跌2.42%，换手率5.09%，成交量10.28万手，成交额2.54亿元。近5日资金流向一览见下表：科兴生物制药融资融券信息显示，融资方面，当日融资买入2557.26万元，融资偿还2616.26万元，融资净偿还58.99万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK1574","01477","BK0239","688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669568711","title":"科兴制药(688136.SH)：GB20注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2669568711","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669568711?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:04","pubTimestamp":1789977886,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药 发布公告，近日，公司全资子公司深圳科兴药业有限公司收到国家药品监督管理局签发的《药物临床试验批准通知书》，国家药监局批准同意深圳科兴自主研发的TL1A单抗创新药物“GB20注射液”开展临床试验。临床前研究表明，GB20注射液的分子具有良好体内外活性，在动物模型上可有效缓解IBD症状，改善肠道功能和细微结构，抗炎和抗纤维化疗效优于对照竞品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IBBJ","PSYK","IBBQ","688136","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667250744","title":"每周股票复盘：科兴制药（688136）将参加科创板创新药业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667250744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667250744?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:24","pubTimestamp":1789237455,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，科兴制药报收于18.98元，较上周的20.34元下跌6.69%。本周，科兴制药9月8日盘中最高价报21.97元。本周关注点公司公告汇总：科兴制药将于2026年9月16日参加科创板创新药行业集体业绩说明会。公司公告汇总科兴生物制药股份有限公司将于2026年9月16日15:00-17:00参加由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会，通过上证路演中心网络互动形式，就公司2026年半年度经营成果、财务状况等与投资者进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239","BK1161","06978","159992","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666511855","title":"科兴制药新提交“-”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666511855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666511855?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:14","pubTimestamp":1789082094,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日科兴生物制药股份有限公司新提交“-”商标注册申请。商标申请详情如下：今年以来科兴生物制药股份有限公司新申请注册商标15件，截止目前公司共持有注册商标720件，另有179件商标尚在注册申请中。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了1.02亿元，同比增24.4%。通过天眼查大数据分析，科兴生物制药股份有限公司共对外投资了22家企业，参与招投标项目703次；财产线索方面有商标信息692条，专利信息57条，著作权信息3条；此外企业还拥有行政许可167个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688136"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665292773","title":"科兴制药（688136）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价上涨2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665292773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665292773?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:58","pubTimestamp":1788861489,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，科兴制药报收于21.61元，较前一交易日上涨2.42%，最新总市值为43.65亿元。科兴生物制药股份有限公司于近日披露《关于参加科创板2026年半年度创新药行业集体业绩说明会的公告》。公告显示，公司将于2026年9月16日15:00-17:00参加由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会，通过上证路演中心网络互动形式，就公司2026年半年度经营成果、财务状况等与投资者进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK0239","688136","06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701028","title":"每周股票复盘：机构净卖出科兴制药（688136）519.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701028","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663701028?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:57","pubTimestamp":1788033458,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，科兴制药（688136）报收于21.59元，较上周的20.55元上涨5.06%。本周，科兴制药8月24日盘中最高价报24.66元。8月24日盘中最低价报21.22元。科兴制药当前最新总市值43.61亿元，在生物制品板块市值排名42/51，在两市A股市值排名3523/5211。本周关注点来自交易信息汇总：8月24日科兴制药现1笔大宗交易，机构净卖出519.2万元交易信息汇总8月24日科兴制药现1笔大宗交易，机构净卖出519.2万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662522782","title":"科兴制药半年报净利大增66%，扣非却亏7836万：主业低迷依赖私募基金价值变动，大股东连续套现","url":"https://stock-news.laohu8.com/highlight/detail?id=2662522782","media":"蓝鲸财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662522782?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:23","pubTimestamp":1787646237,"startTime":"0","endTime":"0","summary":"根据科兴制药半年报，截至半年报报告期末2亿元已经全部投出，累计已投资标的企业28家。科兴制药在半年报中指出，公司营业收入较上年同期下降13.33%，主要受国内外竞争加剧，集采扩面，同时叠加增值税政策变化的影响。2025年，科兴制药实现营收15.34亿元，同比增长9.03%，归母净利润1.56亿元，同比增长394.17%。减持后科兴制药业绩和股价均出现显著下滑，而这一行为也因此受到了市场的密切关注和质疑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787645957820611631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688136","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267221","title":"8月24日科兴制药涨14.84%，国联医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661267221?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:33","pubTimestamp":1787560400,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日科兴制药涨14.84%创60日新高，收盘报23.6元，换手率15.06%，成交量30.43万手，成交额7.13亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为国联基金的国联医疗健康混合A。国联医疗健康混合A目前规模为0.56亿元，最新净值1.3211，较上一交易日下跌5.01%，近一年上涨19.49%。国联医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0239","688136"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793997759115,"stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.3601},{"period":"3month","weight":-0.2346},{"period":"6month","weight":-0.372},{"period":"1year","weight":-0.5773},{"period":"ytd","weight":-0.5033}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"科兴生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16607人(较上一季度增加25.95%)","perCapita":"12162股","listingDate":"2020-12-14","address":"山东省济南市章丘区埠村街道创业路2666号","registeredCapital":"20198万元","survey":" 科兴生物制药股份有限公司的主营业务是重组蛋白、抗体及靶向递送疗法的研发、生产与商业化。公司的主要产品是赛若金、依普定、白特喜、常乐康、引进产品。","listedPrice":22.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴制药,688136,科兴制药股票,科兴制药股票老虎,科兴制药股票老虎国际,科兴制药行情,科兴制药股票行情,科兴制药股价,科兴制药股市,科兴制药股票价格,科兴制药股票交易,科兴制药股票购买,科兴制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}